Vir Biotechnology (VIR) Gross Profit (2020 - 2025)

Vir Biotechnology has disclosed Gross Profit across 6 years of filings, most recently posting $1.2 million for Q2 2025.

• Gross Profit for Q2 2025 came in at $1.2 million, down 60.21% year-over-year; the trailing twelve-month figure through Jun 2025 was $18.3 million (down 75.08% YoY), and the FY2025 annual result was $68.5 million, down 6.58% from the prior year.
• Gross Profit came in at $1.2 million for Q2 2025 at Vir Biotechnology, down from $3.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $1.1 billion in Q1 2022 to a low of $1.2 million in Q2 2025.
• The 5-year median for Gross Profit is $14.3 million (2022), against an average of $151.5 million.
• Across the five-year window, Gross Profit surged 57709.21% in 2022 and sank 99.26% in 2023, its largest moves.
• Vir Biotechnology's Gross Profit stood at $755.9 million in 2021, then sank by 94.26% to $43.4 million in 2022, then plunged by 63.17% to $16.0 million in 2023, then decreased by 26.89% to $11.7 million in 2024, then sank by 89.71% to $1.2 million in 2025.
• The last three Gross Profit figures came in at $1.2 million (Q2 2025), $3.0 million (Q1 2025), and $11.7 million (Q4 2024), per Business Quant data.